No association between low-dose aspirin use and breast cancer outcomes overall: A Swedish population-based study

27Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Results from previous studies indicate that use of low-dose aspirin may improve breast cancer prognosis. We evaluated aspirin use and breast cancer outcomes in relation to clinical characteristics as well as dose and duration of aspirin use. Methods: We used information from the Regional Breast Cancer Quality-of-Care Registries in three Swedish regions to identify 21,414 women diagnosed with a first stage I-III breast cancer between 1 April 2006 and 31 December 2012. The cohort was further linked to nationwide registers to retrieve information about dispensing low-dose aspirin before and after breast cancer diagnosis, comorbidity and causes of death. In a separate analysis, we investigated time to breast cancer death among 621 women with stage IV disease at diagnosis. Associations were evaluated using a multivariable Cox proportional hazards model. Results: Among women with stage I-III breast cancer, 2660 (12.4%) used low-dose aspirin shortly before breast cancer diagnosis and 4091 (19.1%) were users during follow-up. Women were followed for a median of 3.8 years after diagnosis. There was no association between aspirin use and breast cancer-specific death in multivariable analyses (use before diagnosis: hazard ratio (HR) 0.93, 95% confidence interval (CI) 0.77-1.12; use after diagnosis: HR 1.00, 95% CI 0.74-1.37). Similarly, aspirin use was not associated with risk of first recurrence/metastases in a subgroup of stage I-III breast cancer patients (HR 0.97, 95% CI 0.86-1.10). However, in analyses stratified by stage, an inverse association between low-dose aspirin use after diagnosis and breast cancer death was found for women with stage I tumors (HR 0.53, 95% CI 0.29-0.96). Among women with stage IV disease at diagnosis, aspirin use was not associated with time to breast cancer death (HR 0.91, 95% CI 0.67-1.23). Conclusion: In this large population-based cohort study there was no evidence that low-dose aspirin use before or after breast cancer diagnosis is associated with a reduced risk of adverse outcomes overall in breast cancer. However, a potential benefit was noted among women with stage I tumors, warranting further investigation.

Author supplied keywords

References Powered by Scopus

Cancer Statistics, 2017

14390Citations
N/AReaders
Get full text

The Swedish personal identity number: Possibilities and pitfalls in healthcare and medical research

1812Citations
N/AReaders
Get full text

Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis

1465Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Aspirin and cancer survival: A systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers

30Citations
N/AReaders
Get full text

Aspirin and other non-steroidal anti-inflammatory drugs and depression, anxiety, and stress-related disorders following a cancer diagnosis: A nationwide register-based cohort study

27Citations
N/AReaders
Get full text

Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice

26Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Frisk, G., Ekberg, S., Lidbrink, E., Eloranta, S., Sund, M., Fredriksson, I., … Smedby, K. E. (2018). No association between low-dose aspirin use and breast cancer outcomes overall: A Swedish population-based study. Breast Cancer Research, 20(1). https://doi.org/10.1186/s13058-018-1065-0

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

58%

Professor / Associate Prof. 2

17%

Lecturer / Post doc 2

17%

Researcher 1

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 7

47%

Biochemistry, Genetics and Molecular Bi... 4

27%

Nursing and Health Professions 3

20%

Chemical Engineering 1

7%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 38

Save time finding and organizing research with Mendeley

Sign up for free